Teva Pharmaceutical Industries
TEVA
#494
Rank
ยฃ37.65 B
Marketcap
ยฃ32.27
Share price
0.12%
Change (1 day)
72.72%
Change (1 year)

Teva Pharmaceutical Industries (TEVA) - P/B ratio

P/B ratio as of November 2026 : 6.41

According to Teva Pharmaceutical Industries's latest financial reports the company has a price-to-book ratio of 2.88659.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Teva Pharmaceutical Industries - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-314.49-0.52%
2024-12-314.51209.35%
2023-12-311.4623.76%
2022-12-311.1849.93%
2021-12-310.7858-16.53%
2020-12-310.941431.42%
2019-12-310.7163-33.31%
2018-12-311.074.49%
2017-12-311.03-2.23%
2016-12-311.05-46.82%
2015-12-311.98-4.91%
2014-12-312.0839.29%
2013-12-311.497.19%
2012-12-311.39-12.68%
2011-12-311.60-24.99%
2010-12-312.13-17.67%
2009-12-312.5811.69%
2008-12-312.31-15.27%
2007-12-312.7323.77%
2006-12-312.21-52.03%
2005-12-314.6032.62%
2004-12-313.47-27.44%
2003-12-314.78-12.25%
2002-12-315.44

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Novartis
NVS
8.00 24.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.90-70.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.44-77.58%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
8.42 31.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5.61-12.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
4.05-36.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
3.04-52.62%๐Ÿ‡ฎ๐Ÿ‡ณ India